Skip to main content
. 2017 Mar 9;49(2):292–305. doi: 10.4143/crt.2017.118

Table 9.

Crude and age-standardized rates of cancer prevalence by sex on January 1, 2015 in Korea

Site/Type Crude prevalence rate per 100,000a)
Age-standardized prevalence rate per 100,000b)
Both sexes Men Women Both sexes Men Women
All sites 2,885.8 2,543.2 3,228.2 1,837.6 1,730.9 2,027.1
Lip, oral cavity, and pharynx 38.8 52.2 25.3 25.0 35.5 15.8
Esophagus 16.7 30.2 3.3 9.9 20.0 1.7
Stomach 463.3 615.8 310.8 278.1 407.6 171.5
Colon and rectum 398.5 477.1 320.0 237.5 317.6 173.1
Liver 113.6 170.2 57.1 71.8 114.2 33.5
Gallbladderc) 33.6 34.5 32.7 19.4 22.8 16.8
Pancreas 16.7 17.9 15.5 10.2 12.1 8.7
Larynx 18.2 34.3 2.2 10.8 22.8 1.1
Lung 125.0 158.0 92.0 74.5 105.0 51.0
Breast 313.1 2.5 623.5 201.8 1.6 396.8
Cervix uteri 89.0 - 178.0 56.7 - 110.5
Corpus uteri 36.2 - 72.4 23.7 - 46.5
Ovary 31.8 - 63.7 22.2 - 44.0
Prostate 122.6 245.3 - 67.1 160.7 -
Testis 5.1 10.1 - 4.6 9.0 -
Kidney 62.3 84.4 40.2 40.2 57.5 24.9
Bladder 56.3 91.8 20.7 32.1 61.2 10.1
Brain and CNS 18.7 19.3 18.1 16.1 17.0 15.0
Thyroid 646.3 215.6 1076.8 438.4 148.2 726.7
Hodgkin lymphoma 4.6 5.8 3.3 3.8 4.8 2.9
Non-Hodgkin lymphoma 62.2 66.9 57.4 44.1 50.1 38.7
Multiple myeloma 9.5 9.9 9.1 5.8 6.6 5.1
Leukemia 33.8 37.6 30.0 31.7 35.6 28.0
Other and ill-defined 170.0 163.8 176.2 112.0 120.7 104.7

CNS, central nervous system.

a)

Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2014 and who were alive on January 1, 2015. Multiple primary cancer cases were counted multiple times,

b)

Age-adjusted using the Segi’s world standard population,

c)

Includes the gallbladder and other/unspecified parts of the biliary tract.